| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4048504042c7c02a2b369625bd4dcc63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9053effd8078c1314dacb3ac7af29931 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00 |
| filingDate |
1999-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2920d69122a0428424099a49b22b737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7af183d9f4daacb8babc0b7ea76ce7a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96cfc168912d820dcad3f5ce14296ab2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0dc639339c6c216bdcb0233c8091851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32fb13137bfb0ad47fb616decfc22f12 |
| publicationDate |
2002-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-002766-B1 |
| titleOfInvention |
S-SUBSTITUTED THYOL ETHERS 11β-BENZALDOXIMESTRA-4.9-DIENUGOLIC ACID, METHOD OF THEIR RECEIVING AND CONTAINING THESE COMPOUNDS PHARMACEUTICAL COMPOSITIONS |
| abstract |
The application describes the S-substituted thiol esters of 11β-benzaldoxymestra-4,9-di-angular acid of the general formula (I) and their pharmaceutically acceptable salts, as well as a process for preparing these compounds and pharmaceutical compositions containing them. The proposed compounds bind to the progesterone receptor and have a markedly reduced antiglucocorticoid effect. |
| priorityDate |
1998-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |